{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Is Biofrontera, Inc. technically bullish or bearish?
As of June 10, 2025, Biofrontera, Inc. is in a bearish trend with moderate strength, indicated by bearish MACD, moving averages, and KST, while showing signs of consolidation without a clear trend.
What does Biofrontera, Inc. do?
Biofrontera, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, reporting net sales of $9 million and a net loss of $4 million as of March 2025. It has a market cap of $5.97 million and key metrics indicating significant financial challenges.
How big is Biofrontera, Inc.?
As of Jun 18, Biofrontera, Inc. has a market capitalization of 5.97 million, with net sales of 38.00 million and a net profit of -11.53 million over the last four quarters. Shareholder's funds are 4.43 million, and total assets are 22.10 million as of Dec 24.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
